ENTERA BIO LTD (ENTX) Stock Income Statement
NASDAQ:ENTX - Nasdaq - IL0011429839 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 223.00K | 181.00K | 0.00 | 130.00K | 570.00K | |||
| Cost Of Goods | 214.00K | 172.00K | 0.00 | 100.00K | 370.00K | |||
| Gross Profit | 9.00K | 9.00K | 0.00 | 30.00K | 200.00K | |||
| Operating Expenses | 10.10M | 9.59M | 8.89M | 13.05M | 12.42M | |||
| Research and Development | 4.89M | 4.50M | 4.51M | 5.85M | 6.77M | |||
| Selling, General, and Administrative Expenses | 5.21M | 5.09M | 4.43M | 7.25M | 5.69M | |||
| Operating Income | -10.09M | -9.59M | -8.89M | -13.02M | -12.22M | |||
| Interest Income/Expense | 9.00K | 58.00K | 31.00K | 80.00K | -30.00K | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -10.08M | -9.53M | -8.86M | -12.93M | -12.25M | |||
| Income Tax | N/A | 14.00K | 29.00K | 140.00K | -60.00K | |||
| Net Income | -10.09M | -9.54M | -8.89M | -13.07M | -12.19M | |||
| EBITDA | -10.03M | -9.54M | -8.84M | -12.96M | -12.17M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.26 | -0.25 | -0.31 | -0.45 | -0.47 | |||
| Non GAAP EPS | -0.19 | -0.25 | -0.31 | -0.45 | -0.62 | |||
| Statistics | ||||||||
| Gross Profit Margin | 4.04% | 4.97% | N/A | 23.08% | 35.09% | |||
| Profit Margin | -4525.11% | -5271.27% | N/A | -10053.85% | -2138.60% | |||
| Operating Profit Margin | -4522.87% | -5295.58% | N/A | -10015.38% | -2143.86% | |||
All data in USD